United States· US:39892-0811_40b3fbd9-2f55-299f-e063-6394a90a89bc
MediChoice PVP
A povidone-iodine product containing povidone-iodine, registered in United States by O&M HALYARD, INC.. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Povidone-iodine is registered in 12 of 19 countries.
Countries holding a registration under ATC D08AG02 (povidone-iodine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Povidone-iodine · ATC D08AG02
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POVIDONE-IODINE
- Manufacturer
- O&M HALYARD, INC.
- Country
- United States (US)
- ATC code
- D08AG02
- ATC class
- Povidone-iodine
- Defined daily dose
- 0.4 g, T
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11398920811110 BOX in 1 CASE (39892-0811-1) / 50 PACKAGE in 1 BOX / 1 PATCH in 1 PACKAGE / 3 g in 1 PATCH
- ndc1139892081121000 POUCH in 1 CASE (39892-0811-2) / 2.5 g in 1 POUCH
- ndc1139892-0811-1
- ndc1139892-0811-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for povidone-iodine.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Povidone-iodine · interactions on record
1 record
- 1 moderate
Most severe, free to view
- LithiumN05AN01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Povidone-iodine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBETADINELAVIPHARM S.A., Peania, Attica
- Japanポビドンヨード吉田製薬
- United KingdomBetadine 1% gargle and mouthwashMolnlycke Health Care Ltd
- PolandBetadineMedezin Sp. z o.o.
- BelgiumBraunoderm 0.9 % - 45 %B. Braun Melsungen
- SpainACYDONA SOLUCION PARA USO CUTANEOArafarma Group S.A.
- FranceBETADINE 1 %, solution pour gargarisme/bain de boucheCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- NetherlandsBetadine desinfectiedoekjes, geïmpregneerde doek met oplossing voor cutaan gebruik 350 mgCooper Consumer Health B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8653e9f-c2d3-4073-b861-d72dd6068bc3 GET /v1/drugs/a8653e9f-c2d3-4073-b861-d72dd6068bc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10",
"substance": "POVIDONE-IODINE",
"productndc": "39892-0811",
"dosage_form": "SWAB",
"dea_schedule": null,
"strength_unit": "g/100g",
"application_number": "505G(a)(3)",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about povidone-iodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.